Latest / CareTalk: Healthcare. Unfiltered.
Anthropic’s Big Bet on the Future of Biotech
Send us Fan Mail
Anthropic just purchased a one-person biotech run by an AI agent that coordinates 11 outside labs. Is this the blueprint for the "one-person unicorn biotech," or just a snazzy orchestration tool that will run into the usual bottlenecks?
And how does Anthropic’s entry affect its deals with pharma customers and the competition between the US and China for drug industry supremacy?
Hosts David Williams and John Driscoll dig into what Anthropic’s move into biopharma actually means and whether AI can truly reverse the broken economics of drug development.
🎙️⚕️ABOUT CARETALK…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.